(Q34602908)

3 August 2017

1 reference

title

Genetic modeling of estrogen metabolism as a risk factor of hormone-dependent disorders (English)

1 reference

3 August 2017

0 references

Huber JC

1

1 reference

3 August 2017

Schneeberger C

series ordinal

2

1 reference

3 August 2017

Tempfer CB

series ordinal

3

1 reference

3 August 2017

publication date

1 April 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

41 Suppl 1

1 reference

3 August 2017

page(s)

S55-64

1 reference

Estrogen receptor pathways to AP-1.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

P450 enzymes of estrogen metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Molecular mechanisms of estrogen carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Biogenesis and inactivation of catecholestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

High and low activity alleles of catechol-O-methyltransferase gene: ethnic difference and possible association with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Rationale for selective COMT inhibitors as adjuncts in the drug treatment of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Catechol-O-methyltransferase activity: a determinant of levodopa response.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

1 reference

7 January 2021

Catechol-O-methyltransferase genotype and susceptibility to Parkinson's disease in Japan. Short communication.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Variability and validity of polymorphism association studies in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Association between the functional polymorphism of catechol-O-methyltransferase gene and alcohol consumption among social drinkers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Linkage study of catechol-O-methyltransferase and attention-deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

An association study between 5-HTTLPR polymorphism, COMT polymorphism, and Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

P450 in the rat and man: methods of investigation, substrate specificities and relevance to cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

CYP1A1 polymorphisms and lung cancer risk: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Gender differences in genetic susceptibility for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Parental smoking, CYP1A1 genetic polymorphisms and childhood leukemia (Québec, Canada)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Estrogen and oncogene mediated growth regulation of human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Indolo[3,2-b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Effect of transient expression of the oestrogen receptor on constitutive and inducible CYP1A1 in Hs578T human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Role of Estradiol Metabolism and CYP1A1 Polymorphisms in Breast Cancer Risk

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Genetically high susceptibility to oral squamous cell carcinoma in terms of combined genotyping of CYP1A1 and GSTM1 genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Dioxin pollution and endometriosis in Belgium

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Dioxin concentrations in women with endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Expression of dioxin-related transactivating factors and target genes in human eutopic endometrial and endometriotic tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Molecular genetics of primary congenital glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Human CYP1B1 Leu432Val gene polymorphism: ethnic distribution in African-Americans, Caucasians and Chinese; oestradiol hydroxylase activity; and distribution in prostate cancer cases and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

A novel truncating mutation of cytochrome P4501B1 (CYP1B1) gene in primary infantile glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Cloning and sequence of the human gene for P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): similarity with the gene for P450c21

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Association between CYP17 gene polymorphism and risk of breast cancer in young women.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

CYP17 polymorphism in the groups of distinct breast cancer susceptibility: comparison of patients with the bilateral disease vs. monolateral breast cancer patients vs. middle-aged female controls vs. elderly tumor-free women.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

No association of the 5' promoter region polymorphism of CYP17 with breast cancer risk in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

CYP17 promotor polymorphism and ovarian cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Polymorphism T-->C (-34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

A polymorphism in the CYP17 gene is associated with male breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

A polymorphism in the CYP17 gene is associated with prostate cancer risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-actin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Analysis of the aromatase cytochrome P450 gene in human breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Breast cancer risk associated with polymorphism in CYP19 in Japanese women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Tetranucleotide repeat polymorphism at the human aromatase cytochrome P-450 gene (CYP19).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Polymorphic variation in CYP19 and the risk of breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

A tetranucleotide repeat polymorphism inCYP19 and breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

A rare CYP19 (aromatase) variant may increase the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

Genetic variants of CYP19 (aromatase) and breast cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

CYP19 gene polymorphism in endometrial cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2802%2900015-4

7 January 2021

10.1016/S0378-5122(02)00015-4

Identifiers

DOI

1 reference

3 August 2017

1 reference